Technical Analysis for HAE - Haemonetics Corporation

Grade Last Price % Change Price Change
grade A 121.95 -0.76% -0.93
HAE closed down 0.76 percent on Friday, July 19, 2019, on 45 percent of normal volume. The bulls were able to push the stock to a new 52-week high.

Earnings due: Aug 6

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Flat
See historical HAE trend table...

Date Alert Name Type % Chg
New 52 Week High Strength 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength -0.76%
Slingshot Bullish Bullish Swing Setup -0.04%
Overbought Stochastic Strength -0.04%
Bearish Engulfing Bearish -0.51%
New 52 Week High Strength -0.51%
Outside Day Range Expansion -0.51%
Overbought Stochastic Strength -0.51%
New 52 Week Closing High Bullish -1.17%

Older signals for HAE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Haemonetics Corporation engages in the design, development, manufacture, and marketing of automated blood component collection devices and surgical blood salvage devices in the United States and internationally. It provides various plasma products, including PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; and blood center products comprising multicomponent collection system brand apheresis equipment to collect specific blood components integrated from the donor, automated cell processor brand solution to automate the washing and freezing of red cell components in the lab, and filtration products. The company also offers various hospital products, such as TEG thrombelastograph hemostasis analyzer system that measures a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver system for cardiovascular surgery procedures; OrthoPAT surgical blood salvage system for orthopedic procedures; cardioPAT system to open heart surgeries; and IMPACT Online Web-based software platform that monitors and measures improvements in a hospital's blood management practices, provides hospitals with a view of their blood management metrics, and helps monitor transfusion rates. In addition, it offers SafeTrace Tx and BloodTrack suite of solutions, as well as El Dorado Donor donation and blood unit management systems. The company markets and sells its products to commercial plasma collectors, blood collection groups and independent blood centers, hospitals and hospital service providers, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.
Medicine Information Technology Medical Specialties Supply Chain Blood Transfusion Medicine Hematology Blood Clots Blood Transfusion Filtration Products Blood Plasma Hemostasis Plasma Products Web Based Software Platform
Is HAE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 124.19
52 Week Low 80.23
Average Volume 479,774
200-Day Moving Average 99.7288
50-Day Moving Average 110.212
20-Day Moving Average 120.269
10-Day Moving Average 121.864
Average True Range 2.1182
ADX 60.18
+DI 32.2578
-DI 6.8673
Chandelier Exit (Long, 3 ATRs ) 117.8354
Chandelier Exit (Short, 3 ATRs ) 119.7946
Upper Bollinger Band 124.5157
Lower Bollinger Band 116.0223
Percent B (%b) 0.7
BandWidth 7.062003
MACD Line 3.5805
MACD Signal Line 4.13
MACD Histogram -0.5495
Fundamentals Value
Market Cap 6.42 Billion
Num Shares 52.6 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 1524.38
Price-to-Sales 2.78
Price-to-Book 3.19
PEG Ratio 3.50
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 125.42
Resistance 3 (R3) 125.78 124.98 124.84
Resistance 2 (R2) 124.98 124.10 124.80 124.64
Resistance 1 (R1) 123.47 123.56 123.07 123.11 124.45
Pivot Point 122.67 122.67 122.48 122.49 122.67
Support 1 (S1) 121.16 121.79 120.76 120.80 119.45
Support 2 (S2) 120.36 121.25 120.18 119.26
Support 3 (S3) 118.85 120.36 119.06
Support 4 (S4) 118.49